insights_auto
Why is ANTH up 35.00%?
Dive Deeperchevron_right
ANTH:OTCMKTS
Anthera Pharmaceuticals Inc
$0.00014
arrow_upward
+35.00%(+0.000035) 1D
Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANTH...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
3.53K
Avg. vol.
772.00
Volume
149.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
3.53K
Avg. vol.
772.00
Volume
149.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
News stories
From web sources and news partners
FXLeaders
·
4 hours ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
CryptoRank
·
12 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Traders Union
·
6 hours ago
Yuriy Matso: S&P500 negative beta to SPY at record 18.9 percent
24/7 Wall St.
·
13 hours ago
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profile
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase, Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency is currently in Phase 3 clinical trials, and A-623 for the treatment of IgA nephropathy is currently in Phase 2 clinical trial. Wikipedia
About Anthera Pharmaceuticals Inc
CEO-
Employees21
Founded2004
HeadquartersHayward, California, United States
SectorBiotechnology
Websiteanthera.com